Concepedia

Georg Schlechtingen

GS

10

Publications

603

Citations

10

H-Index

1995

Active since

Affiliations

Karlsruhe Institute of Technology(Current)

Max Planck Institute of Molecular Cell Biology and Genetics

Technische Universität Dresden

Cubist Pharmaceuticals (United States)

Clinical Research Institute

Georg Schlechtingen is an author at Karlsruhe Institute of Technology specializing in pharmacology, chemistry, and organic chemistry.

Top concepts

PharmacologyChemistryOrganic ChemistryEngineeringBiochemistryNatural SciencesMedicineCatalysisDrug DiscoveryBiomolecular Engineering

Publications per year

1995–2013

10

Publications

10

Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting

Lawrence Rajendran, Anja Schneider, Georg Schlechtingen et al. · Science · 2008 · 255 citations

Proteinlipid Interaction, Neurodegenerative Diseases, Protein Secretion +11

A Novel Method for the Synthesis of Isocyanates Under Mild Conditions

Hans‐Joachim Knölker, Tobias Braxmeier, Georg Schlechtingen · Angewandte Chemie International Edition in English · 1995 · 150 citations

Novel Method, Derivatives, Catalytic Amount +15

Isocyanates, Part 2.7 Synthesis of Symmetrical and Unsymmetrical Ureas by DMAP-Catalyzed Reaction of Alkyl- and Arylamines with Di-tert-butyldicarbonate

Hans‐Joachim Knölker, Tobias Braxmeier, Georg Schlechtingen · Synlett · 1996 · 41 citations

Engineering, Part 2.7, Organic Chemistry +6

First total synthesis of carbazomycin C and D 1

Hans‐Joachim Knölker, Georg Schlechtingen · Journal of the Chemical Society Perkin Transactions 1 · 1997 · 36 citations

Carbazomycin C, Physics, Natural Sciences +10

[Pro<sup>3</sup>]Dyn A(1−11)-NH<sub>2</sub>: A Dynorphin Analogue with High Selectivity for the κ Opioid Receptor

Georg Schlechtingen, Li Zhang, Alan L. Maycock et al. · Journal of Medicinal Chemistry · 2000 · 32 citations · Full text

Rows per page

1–5 of 10